Grace Therapeutics (L8S.F) Q3 2026 Earnings

Aug 13Confirmed
Q3 2025
Q4 2025
Q1 2026
Q3 2026
-0.79
-0.54
-0.3
-0.05

Details

Expected EPS
-0.112109565
Actual EPS
-0.7890155
Surprise EPS
-0.68
Surprise Percent
-603.79%

Description

⁨Grace Therapeutics⁩ (⁦L8S.F⁩) has reported earnings of ⁦-0.7890155⁩ per share for ⁦Q3 2026⁩.

0 Comments

Share your thoughts